MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income
-$285,422K
(10.46%↑ Y/Y)
Net Product
Revenues
$124,844K
Collaboration Revenue
$42,367K
Milestone Revenue
$5,141K
Loss from operations
-$273,084K
(19.60%↑ Y/Y)
Total other income
-$12,338K
(-158.99%↓ Y/Y)
Total revenue
$172,352K
(2144.17%↑ Y/Y)
Interest income
$22,730K
(-12.88%↓ Y/Y)
Total operating
expenses
$445,436K
(22.59%↑ Y/Y)
Royalty interest
expense
$33,779K
Other expense, net
-$1,283K
(-419.43%↓ Y/Y)
Other interest
(expense) income
$6K
(-99.88%↓ Y/Y)
Research and development
expenses
$258,784K
(7.09%↑ Y/Y)
Selling, general and
administrative
$179,682K
(48.65%↑ Y/Y)
Cost of product sales
$6,970K
(743.83%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Syndax Pharmaceuticals Inc (SNDX)
Syndax Pharmaceuticals Inc (SNDX)